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Abstract
Background
Few epidemiological studies have examined the association between dietary trans fatty
acids and weight gain, and the evidence remains inconsistent. The main objective of the
study was to investigate the prospective association between biomarker of industrial trans
fatty acids and change in weight within the large study European Prospective Investigation
into Cancer and Nutrition (EPIC) cohort.
Methods
Baseline plasma fatty acid concentrations were determined in a representative EPIC sam-
ple from the 23 participating EPIC centers. A total of 1,945 individuals were followed for a
median of 4.9 years to monitor weight change. The association between elaidic acid level
and percent change of weight was investigated using a multinomial logistic regression
model, adjusted by length of follow-up, age, energy, alcohol, smoking status, physical activi-
ty, and region.
Results
In women, doubling elaidic acid was associated with a decreased risk of weight loss (odds
ratio (OR) = 0.69, 95% confidence interval (CI) = 0.55-0.88, p = 0.002) and a trend was ob-
served with an increased risk of weight gain during the 5-year follow-up (OR = 1.23, 95%
CI = 0.97-1.56, p = 0.082) (p-trend<.0001). In men, a trend was observed for doubling elaidic
acid level and risk of weight loss (OR = 0.82, 95%CI = 0.66-1.01, p = 0.062) while no signifi-
cant association was found with risk of weight gain during the 5-year follow-up (OR = 1.08,
95% CI = 0.88-1.33, p = 0.454). No association was found for saturated and cis-
monounsaturated fatty acids.
Conclusions
These data suggest that a high intake of industrial trans fatty acids may decrease the risk of
weight loss, particularly in women. Prevention of obesity should consider limiting the con-
sumption of highly processed foods, the main source of industrially-produced trans
fatty acids.
Introduction
The worldwide increase in obesity, especially among young-age populations and low socio-eco-
nomical groups, has largely been driven by the global nutrition transition that promotes a
chronic energy imbalance, typically characterized by increases in the consumption of highly
processed foods, sugar-sweetened beverages, refined carbohydrates, salt, and saturated and
trans fatty acids (TFA) [1–3], with genetic factors likely modifying individual susceptibility to
these dietary factors [4]. This change is coupled with lifestyles leading to reduced daily energy
expenditure (e.g. increased television watching, less physical activity, more sedentary behav-
iors). Energy imbalance leads to storage of excess energy in adipocytes, which exhibit both hy-
pertrophy and hyperplasia, endoplasmic reticulum stress, and mitochondrial dysfunction,
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leading to increased intracellular release of adipokines, free fatty acids, and inflammatory me-
diators that cause adipocyte dysfunction [4].
Several epidemiological studies have examined the association between dietary fatty acids
and weight gain, but the epidemiological evidence remains scarce and inconsistent [5]. Specifi-
cally, there is still limited evidence that increased intake of industrial TFA may result in weight
gain [6]. One of the major limitations in epidemiological studies relates to the imprecision in
estimating fatty acid intake using traditional dietary questionnaires. Moreover, the conversion
of food items into their fatty acid content is exceptionally complex for numerous reasons, in-
cluding the variation of fatty acid composition within the same food according to cooking
methods and industry supply, and the incompleteness of food composition tables, particularly
regarding TFA isomers. In contrast, biomarkers of dietary fatty acids offer objective, qualitative
measures of bioavailable amounts of some specific fatty acids irrespective of the source and
quality of foods [7, 8]. Specifically, we recently showed that plasma phospholipid elaidic acid
concentrations, the main TFA isomer occurring during partial hydrogenation of vegetable oils
and found in a myriad of industrial foods, were positively correlated to the intake of highly pro-
cessed foods within the European Prospective Investigation into Cancer and Nutrition (EPIC)
cohort [9]. In this regard, the use of biomarkers of dietary industrial TFA and highly processed
foods in epidemiological studies could provide key insights into the relationship between in-
dustrial TFA and weight gain.
Thus, the main objective of this study was to investigate the association between baseline
plasma phospholipid fatty acid concentrations, with a particular focus on TFA from
industrial food sources, and subsequent weight change within the EPIC-PANACEA
(Physical Activity, Nutrition, Alcohol, Cessation of Smoking, Eating out of Home and
Obesity) study.
Materials and Methods
Population
The rationale and design of the EPIC study have been previously reported [10, 11]. The EPIC
cohort consists of more than 500,000 subjects distributed among 23 centres in 10 European
countries (Denmark, France, Greece, Germany, Italy, the Netherlands, Norway, Spain, Sweden
and United Kingdom). Between 1992 and 2000, country-specific dietary questionnaires (food
frequency questionnaires or diet history questionnaires), standardized lifestyle, anthropometric
data and blood samples were collected at baseline from the study participants. Blood samples
were collected from most participants at baseline (1992–1998). In each of the 23 centres, blood
samples of at least 30mL were drawn from most participants and stored at 5–10°C protected
from light and transported to local laboratories for processing and aliquoting. The only excep-
tions were the EPIC-Oxford centre (United Kingdom) where blood samples were collected
from a network of general practitioners and transported to a central laboratory by post, and
centres in Sweden and Denmark where blood was aliquoted within one hour of drawing. In all
countries, except Denmark and Sweden, blood was separated into 0.5mL fractions (serum,
plasma, red cells and buffy coat for DNA extraction). Each fraction was placed into straws,
which were heat sealed and stored under liquid nitrogen. In Denmark, blood fraction aliquots
of 1.0mL were stored locally in Nunc tubes at -150°C under nitrogen vapour. In Sweden, sam-
ples were stored in -80°C freezers.
The EPIC-PANACEA study is a subcohort of EPIC where repeated measures of anthro-
pometry are available, which aimed at determining predictors of body weight and subsequent
changes in weight [12].
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Ethics Statement
All participants gave written or oral informed consent. The study was approved by the Interna-
tional Agency for Research on Cancer Ethical Review Committee and by local ethical commit-
tees at the participating centres.
Selection Criteria
Plasma phospholipid fatty acid were measured in a sub-analysis of the EPIC study [7], for
which detailed and standardized 24-hour dietary recalls (24-HDRs) were collected [13, 14]. For
the purpose of these analyses, 16 geographical regions were designated by grouping some of
the 23 participating EPIC centers together: France (Paris and surroundings), Northern Italy
(Varese/Turin), Central Italy (Florence), Southern Italy (Ragusa/Naples), Northern Spain (San
Sebastian, Navarra, Asturias), South-Eastern Spain (Murcia), Southern Spain (Granada),
Greece (Athens and other regions), Northern Sweden (Umeå), Southern Sweden (Malmö),
Denmark (Aarhus and Copenhagen), UK (Oxford, the health conscious group, vegans and
ovo-lacto-vegetarians), UK (Cambridge, the General population), The Netherlands (Utrecht
and Bilthoven), former East Germany (Potsdam), and South-West Germany (Heidelberg).
Except for France, where only women were recruited, 100 men and 100 women were ran-
domly selected from each of the 16 regions, with equal numbers of subjects selected for each
season at which their blood sample was collected. Thirty percent of samples were fasting. In
total, 3,003 subjects were finally randomly selected for participation in this study from those
who completed information on FFQ and 24-HDRs, and those with available blood samples.
The exclusion criteria for the present study were length of follow-up equals to 0, extreme re-
ported energy intake (<1% and>99% percentile of the ratio of reported energy intake estimat-
ed through country-specific dietary questionnaires to estimated energy requirement), missing
information on weight or height at baseline or extreme anthropometric measurements
(height<130cm, body mass index<16kg/m2), missing weight at follow-up, missing informa-
tion on lifestyle (tobacco or alcohol consumption), pregnancy, or chronic disease (prevalent di-
abetes, cancer or cardiovascular disease) at enrollment. The final population consisted of 1,998
individuals (54% women). Finally, elaidic acid measured through gas chromatography was not
well separated in 53 chromatograms, leading to further exclusions and a total number of 1,945
individuals retained in this analysis.
Assessment of Anthropometric Measures andWeight Change
Body weight and height were measured at baseline according to standardized procedures previ-
ously described [15]. Weight was measured to the nearest 0.1kg and height was measured to
the nearest 0.1, 0.5, or 1.0cm depending on the center, without shoes. The body mass index
(BMI) was calculated as body weight in kilograms divided by squared height in meters (kg/m2).
At follow-up (ranging from 2 to 11 years), information on weight was collected through
questionnaires in all centers, except in the Bilthoven (The Netherlands) and Cambridge (UK)
centers. In the Bilthoven center, weight was measured by trained staff for 57 persons, and self-
reported values were collected from 56 persons. In the Cambridge center, weight was measured
by trained staff. No follow-up data were available from Ragusa and Turin centers in Italy.
As the follow-up times differed by center, we calculated the weight change at 5 years (kg/5y)
as (weight at follow-up—weight at baseline) x 5/years of follow-up. The weight at 5 years, de-
termined adding the weight change at 5 years to the weight at baseline, and the BMI at 5 years
were also obtained. The outcome measure used in our analysis was the percent of weight
change at 5 years, computed as (weight at 5 years minus weight at baseline/weight at baseline)
x100, and expressed as a percentage.
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Laboratory Analysis
Details on plasma phospholipid fatty acid measurements through gas chromatography were pre-
viously provided [16]. Samples of the same sex and age category were ordered randomly within
analysis batches, and each batch included one subject from each participating centre and one
sample from a standard pool for the quality control. Briefly, lipids were extracted from 200μl
plasma, phospholipids were purified by solid-phase extraction, fatty acid methyl esters were
formed by transmethylation of the phospholipids and analyzed by gas chromatography on a
30-m polar column. The relative amount for each fatty acid was expressed as the percentage of
total area. The laboratory analysis method allowed for the analysis of twenty-two individual fatty
acids with a chain length between 14 and 22 carbons belonging to different fatty acid classes: sat-
urated fatty acids, monounsaturated fatty acids including one trans isomer, elaidic acid (trans
18:1n-9), n-3 polyunsaturated fatty acids and n-6 polyunsaturated fatty acids. Analytical quality
control was carried out by the daily use of a standard quality control plasma (n = 137). The coef-
ficients of variation (CV) for fatty acids were previously provided [7]. They ranged from 1.91%
for major peaks such as stearic acid to 12.75% for minor peaks such as α-linolenic acid. CV was
5.38% specifically for elaidic acid. All analyses were performed at the IARC-WHO laboratory.
Statistical Analysis and Data Treatment
The association between plasma phospholipid fatty acids and percent change of weight at
5 years was investigated using a multinomial logistic regression model. The percent change of
weight at 5 years was categorized according to tertiles, i.e. for individuals showing a 5-year per-
cent variation<-1.6%; between-1.6% and 2.8%;> 2.8%. Odds ratios expressing the risk of in-
creasing (decreasing) weight at 5 years were computed comparing the top (bottom) tertile
category versus the second, which was used as the reference category. The exposure variables
were fatty acid concentrations, and were modeled as continuous variables, after log 2 transfor-
mation to express the variation in risk of percent of weight gain and weight loss associated to
doubling the concentration level. Models were adjusted by length of follow-up (years),
age (years), energy intake (kcal/day), alcohol intake (g/day), smoking status (never, former,
current), physical activity (inactive, moderately inactive, moderately active, active), and region.
Analyses were carried out for women and men separately.
Statistical tests were 2-sided, and p-values<0.05 were considered significant. All statistical
analyses were performed using SAS statistical software (version 9.4, SAS Institute Inc, Cary,
NC, USA).
Results
The median follow-up time was 5.0 years (range 2.5–9.9 years) among women and 4.9 years
(range 2.7–9.9 years) among men. Table 1 presents the baseline characteristics of the study
population across sex-specific tertiles of plasma phospholipid elaidic acid level defined on the
whole sample (i.e. including all studied regions), expressed as percentage of total fatty acids.
In men, increasing tertiles of elaidic acid level were associated with a greater likelihood of
having a post-graduate education, never smoking, and being active, and with decreasing in-
takes of energy, total fat (monounsaturated fat) and alcohol. In women, increasing tertiles of
elaidic acid level were associated with a greater likelihood of having a post-graduate education,
smoking, and with decreasing intake of alcohol and monounsaturated fat.
Fig. 1 shows the center mean weight change (%) at 5 years in men and in women across cen-
ters. The median weight change at 5-year follow-up was 0.86% (95% central range = -12.3 to
11.9%) among women and 0.56% (95% central range = -9.2 to 11.1%) among men. The base-
line median proportion of elaidic acid (18:1n-9trans), the main trans fatty acid isomer
Plasma Elaidic Acid andWeight Change
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originating from industrial processing of foods, was 0.18% of total fatty acids among women
(95% central range = 0.07–0.39), and 0.12% in men (95% central range range = 0.04–0.34).
In women, doubling elaidic acid was associated with a decreased risk of weight loss (odds
ratio (OR) = 0.69, 95% confidence interval (CI) = 0.55–0.88, p = 0.002) and a trend was ob-
served with an increased risk of weight gain during the 5-year follow-up (OR = 1.23, 95% CI =
0.97–1.56, p = 0.082) (p-trend<.0001) (Fig. 2). In men, a trend was observed between doubling
elaidic acid level and risk of weight loss (OR = 0.82, 95% CI = 0.66–1.01, p = 0.062) while no
significant association was found with risk of weight gain during the 5-year follow-up (OR =
1.08, 95% CI = 0.88–1.33, p = 0.454) (Fig. 2).
Table 1. Baseline characteristics of the study population across sex-speciﬁc tertiles of plasma phospholipid elaidic acid level.
Elaidic acid (%)
Men (869) Women (1077)
< 0.12 [0.12–0.20]  20 p-valuea < 0.12 [0.12–0.20]  20 p-valuea
431 254 184 217 395 465
Mean age (yrs) 54.4 (0.3) 54.9 (0.4) 53.5 (0.4) 0.16 55.7 (0.4) 54.6 (0.3) 53.6 (0.3) <.0001
Mean weight (kg) 81.5 (0.5) 80.3 (0.7) 77.9 (0.8) 0.0006 69.2 (0.8) 66.9 (0.6) 65.9 (0.5) <.0001
Mean BMI 27.3 (0.2) 26.2 (0.2) 25.0 (0.2) <.0001 27.8 (0.3) 26.0 (0.2) 25.1 (0.2) <.0001
Educational level (%)
None 11 2 2 <.0001 25 10 5 <.0001
Primary school completed 26 24 23 31 31 20
Technical/professional school 20 24 29 9 23 29
Secondary school 17 13 10 19 18 21
Longer education (including University
degree)
26 37 36 16 18 25
Smoking status (%)
Never 29 36 39 0.0003 72 67 62 0.01
Former 41 42 39 11 22 23
Current 30 22 22 17 11 15
Physical activity (%)
Inactive 21 16 18 0.10 35 28 25 0.07
Moderately inactive 33 31 31 37 38 37
Moderately active 28 25 25 18 20 25
Active 18 28 26 10 14 13
Menopause (%)
Pre - - - - 18 20 23 0.001
Peri - - - 69 60 55
Post - - - 13 20 22
Mean total energy intake (kcal/day) 2550.8
(32.5)
2299.0
(42.4)
2313.5
(49.8)
<.0001 1959.2
(36.4)
1927.8
(27.0)
1936.7
(24.9)
0.90
Mean total fat (g/day) 99.8 (1.6) 92.3 (2.1) 94.0 (2.5) 0.009 78.1 (1.9) 76.7 (1.4) 79.8 (1.3) 0.35
Mean saturated fat (g/day) 33.0 (0.7) 34.2 (0.9) 36.3 (1.0) 0.006 25.5 (0.8) 27.9 (0.6) 29.6 (0.6) 0.001
Mean monounsaturated fat (g/day) 43.3 (0.8) 35.5 (1.1) 33.8 (1.2) <.0001 33.7 (0.9) 30.1 (0.7) 29.9 (0.6) 0.001
Mean total polyunsaturated fat (g/day) 15.3 (0.3) 15.5 (0.4) 17.4 (0.5) 0.005 12.4 (0.4) 12.3 (0.3) 14.2 (0.3) <.0001
Mean alcohol intake (g/day) 25.3 (1.0) 14.7 (1.3) 12.1 (1.5) <.0001 8.9 (0.7) 7.6 (0.5) 6.6 (0.5) 0.002
ap-values from the regression of the considered variable (continuous or categorical) on the log-transformed elaidic acid levels
doi:10.1371/journal.pone.0118206.t001
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Besides trans elaidic acid, no significant association was found in women or in men
between individual levels of saturated fatty acids (palmitic acid, stearic acid, pentadecanoate,
heptadecanoate), cis-monounsaturated acids (palmitoleic acid, oleic acid), or the sum of
elaidic acid and saturated fatty acids and percent of weight change at 5 years (data not
tabulated).
Discussion
This large epidemiological study conducted within the EPIC cohort provides unique data on
biomarkers of industrial TFA and their associations with weight change at 5-year follow-up.
We showed evidence that doubling elaidic acid level measured at baseline was associated with
a decreased risk of weight loss and a trend was observed with an increased risk of weight gain,
particularly in women. This association is specific to elaidic acid, as saturated and cis-
monounsaturated fatty acids were not significantly associated with weight change. In a previ-
ous study within the EPIC cohort, no significant association was found between baseline
plasma levels of n-3 polyunsaturated fatty acids and subsequent weight change [17].
Fig 1. The EPIC regions (n = 16) were ordered from South to North. These geographical regions were designated by grouping some of the 23 EPIC
centers together: France (Paris and surroundings), Northern Italy (Varese), Central Italy (Florence), Southern Italy (Naples), Northern Spain (San Sebastian,
Navarra, Asturias), South-Eastern Spain (Murcia), Southern Spain (Granada), Greece (Athens and other regions), Northern Sweden (Umeå), Southern
Sweden (Malmö), Denmark (Aarhus and Copenhagen), UK (Oxford, the health conscious group, vegans and ovo-lacto-vegetarians), UK (Cambridge, the
General population), The Netherlands (Utrecht and Bilthoven), former East Germany (Potsdam), and South-West Germany (Heidelberg).
doi:10.1371/journal.pone.0118206.g001
Plasma Elaidic Acid andWeight Change
PLOS ONE | DOI:10.1371/journal.pone.0118206 February 12, 2015 7 / 11
Dietary Sources of Elaidic Acid
Trans-monounsaturated fatty acids represent a class of exogenous fatty acids, not synthesized by
humans, originating either from ruminant animal meat and dairy fat, mostly vaccenic acid and
conjugated linoleic acid, or from partially hydrogenated vegetable oils, used as a substitute for
saturated fats in some margarines and industrially highly processed foods, mostly elaidic acid
[18]. Ultra-processed products, a type of process that has become increasingly predominant, at
first in high-income countries, and now in low and middle-income countries, creates ready-to-
consume food products that are energy-dense, and contain TFA, sugar and salt [19, 20]. Even if
the intake of TFA has decreased in some high-income countries (e.g. Denmark, Norway, Cana-
da), the increasing worldwide consumption of ultra-processed foods implies that certain sub-
groups of the population in both high, low and middle-income countries can reach high intake
of industrial TFA [21].
Trans Fatty Acids and Obesity
We previously showed that elaidic acid concentrations measured in plasma phospholipids
were positively correlated to dietary intake of highly processed foods in a cross-sectional study
Fig 2. The associations between plasma phospholipid fatty acids and percent of weight change at
5 years were investigated using amultinomial logistic regressionmodel. The percent of weight change at
5 years was estimated as (weightat 5 years minus weight at baseline/weight at baseline)*100, and expressed
as a percentage. Weight change during the follow-up was categorized according to tertiles considering the
middle category as the reference category (i.e. stable weight at 5 years in %, -1.59;2.83%). The highest tertile
(3, weight gain in %,>2.83%) and the lowest (1, weight loss in %,<-1.59%) were compared to the reference
category. Exposure variables (fatty acid concentrations 2 log-transformed) were modeled as continuous
variables. The model was adjusted by length of follow-up, age, energy and alcohol intakes, smoking status,
physical activity, and region. Analyses were carried out for women and men separately.
doi:10.1371/journal.pone.0118206.g002
Plasma Elaidic Acid andWeight Change
PLOS ONE | DOI:10.1371/journal.pone.0118206 February 12, 2015 8 / 11
conducted within the EPIC cohort, indicating that plasma phospholipid elaidic acid is a reliable
biomarker of highly processed foods [9]. The trend for a positive association that we reported
between baseline plasma levels of elaidic acid and weight gain is consistent with data from a
cross-sectional study conducted in Costa Rica, showing positive association between adipose
tissue levels of 18:2trans fatty acids originating mostly from partially hydrogenated oils, and
BMI, while a negative association was found between total 18:1trans and BMI, suggesting that
specific TFA isomers may have divergent effects on adiposity [22]. However, a recent cohort
study conducted in Denmark found no significant association between baseline adipose tissue
levels of total TFA or TFA from dairy foods and weight change years after enrolment [23].
Some studies support that this association between industrial TFA and adiposity may be causal
[24, 25]. Industrial TFA isomers serve as ligands for the peroxisome proliferator-activated re-
ceptors-γ system and can exert a biological effect that promotes abdominal obesity [24]. A ran-
domized trial in monkeys showed evidence that supplementation with industrial TFA isomers
induce weight gain and abdominal adiposity, with evidence that there is impaired insulin re-
ceptor binding signal transduction [25]. Growing evidence for this specific effect is particularly
concerning given the worldwide obesity pandemic and high contents of industrially produced
TFA in many foods toward children.
This study has some limits. Firstly, biomarkers of fatty acids are available only at baseline,
and the possibility that changes in plasma phospholipid fatty acid levels might have changed
during the follow-up is not known. Secondly, BMI, especially when the measure is based on
self-reported height and weight, is an insensitive measure of body fat compared with more sen-
sitive and direct approaches such asDEXA. Thirdly, this study was limited by the inability to re-
solve TFA isomers other than elaidic acid. Finally, as in other observational studies, we cannot
rule out the possibility that the association we observed resulted from confounding bias, al-
though we adjusted for known factors related to elaidic acid.
In conclusion, these data suggest that a high intake of TFA originating from industrial pro-
cessing of foods is associated with decreased risk of weight loss, particularly in women. Further
research is needed to explore the causality of the associations and the underlying biological
plausibility. Prevention of obesity should consider limiting the consumption of highly pro-
cessed foods, the source of industrially-produced TFA. Particularly, existing industrial process-
es generating TFA (partially hydrogenated vegetable oils) should be curbed, as undertaken in
some countries—Denmark, Canada, and New York City for a few years now. This evidence is
highly relevant and provides a strong rationale for obesity prevention in populations that have
experienced the nutritional transition.
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